BiondVax Pharma (BVXV) Reports Q2 Loss of NIS0.05/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BVXV Hot Sheet
Join SI Premium – FREE
BiondVax Pharma (NASDAQ: BVXV) reported Q2 EPS of (NIS0.05), versus (NIS0.02) reported last year.
For earnings history and earnings-related data on BiondVax Pharma (BVXV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ACM Research (ACMR) Tops Q3 EPS by 6c ; Offers Guidance
- NorthWestern (NWE) Misses Q3 EPS by 16c; Offers Guidance
- Haemonetics (HAE) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
